The Honey Pot Company, LLC (“The Honey Pot Co.” or “the Company”),
a leading “better-for-you” feminine care brand, together with its
partner, Compass Diversified (NYSE: CODI) (“CODI”), proudly
announces the appointment of three new directors - Janis
Smith-Gomez, former executive of Johnson & Johnson; Dr. Maria
Sophocles, a practicing gynecologist and the Medical Director and
Founder of Women's Healthcare of Princeton; and JuE Wong, former
President & CEO of Olaplex - to its Board of Directors,
effective April 17, 2024.
Ms. Janis Smith-Gomez brings visionary
commercial and marketing expertise honed throughout her impressive
career as an executive of several iconic brands in the consumer
goods and health segments. From 2006 to 2022, she held several
leadership roles at Johnson & Johnson, including Vice President
of US Marketing for its skin health and beauty portfolio, and most
recently served as Vice President of Global Brand Experience and
Corporate Brand Development for its Medical Devices division. Prior
to Johnson & Johnson, Ms. Smith-Gomez held general management
and marketing roles at Mars, Kraft Foods, and PepsiCo. She began
her career in strategy consulting at Booz Allen Hamilton. She
currently sits on the boards of The New York Academy of Medicine,
Envoy Medical Corporation, and Black Public Media.
“I am honored to be partnering with The Honey
Pot Co., a purpose-driven brand whose mission of empowering women
and leading the conversation around feminine health through
education deeply aligns with my values,” said Ms. Smith-Gomez. “I
look forward to collaborating with the talented leadership team to
continue raising awareness of the organization’s innovative
products and delivering positive wellness outcomes to its
community.”
Dr. Maria Sophocles joins with thirty years of
experience as a practicing gynecologist and advocate for
underserved categories in women’s healthcare, including menopause
care and sexual wellness. A TED speaker and sought-after HealthTech
advisor, she also serves as the Chief Medical Officer at Embr Labs,
the Medical Director of Women’s Health at CURIA Health, and as an
advisor to Flow Health. Dr. Sophocles is a Fellow of the American
Board of Obstetrics and Gynecology and holds numerous
certifications from international and national medical societies
for her contributions to gynecology.
Dr. Sophocles added, “As a gynecologist, I am
deeply attuned to my patients’ health and well-being and have
insight into where the market lacks products that sufficiently meet
their needs. I fully embrace The Honey Pot Co.’s innovative
approach to holistic wellness and am excited to share my
perspectives on how we can improve access to healthier and more
effective solutions to help people feel more comfortable and
confident.”
Ms. JuE Wong brings deep industry knowledge and
experience in scaling innovative, high-growth, premium brands
across the beauty and personal care sector. Ms. Wong is a seasoned
executive, having previously served as the President and/or CEO of
Olaplex, Moroccan Oil, StriVectin, Elizabeth Arden, and Astral
Brands. She has also held roles at ZO Skin Health, Perricone MD,
Murad, Henkel, PepsiCo, and Cargill. Ms. Wong currently sits on the
board of FireFly Automatix and on the advisory board of Versicolor
Technologies.
“I have been impressed by The Honey Pot Co.’s
growth trajectory and how quickly it has established market
leadership in its core categories,” said Ms. Wong. “As a member of
The Honey Pot Co. Board, I am delighted to share learnings from my
many years of experience with personal care brands with a
leadership team that mirrors my passion for disrupting the status
quo and doing well by doing good.”
Raj Dalal, Chairman of The Honey Pot Co.,
commented on behalf of CODI: “We are excited to add such high
caliber talent to the board. Janis, Maria, and JuE are leaders in
their respective industries and will contribute invaluable insight
and diverse perspectives to support the Company in its next phase
of growth.”
Beatrice Dixon, Co-Founder, CEO, and Chief
Innovation Officer of The Honey Pot Co., echoed this sentiment,
emphasizing the importance of diverse female voices steering
conversations around feminine wellness. “Welcoming Janis, Maria,
and JuE to our board is a testament to our commitment to empowering
humans and promoting holistic wellness. Their depth of knowledge
and passion mirror our ongoing vision to formulate a more
transparent world.”
With the addition of this dynamic board, The
Honey Pot Co. stands poised to embark on a new chapter of
innovation and growth, further solidifying its position as a
trailblazer in personal wellness.
About The Honey Pot Co.
The Honey Pot Co. is a leading feminine care
brand, powered by plant-derived ingredients and clinically tested
formulas. Founded in 2012 by CEO Beatrice Dixon, The Honey Pot Co.
is rooted in the belief that all products should be made with
healthy and efficacious ingredients that are kind to and safe for
skin. The company offers an extensive range of holistic wellness
products across the feminine hygiene, menstrual, personal care, and
sexual wellness categories. The Honey Pot Co.’s mission is to
educate, support, and provide consumers around the world with tools
and resources that promote menstrual health and vaginal wellness.
Their products can be found in more than 33,000 stores across the
U.S. including Target, Walmart, CVS, and Walgreens, as well as
online. For more information on The Honey Pot Co., please
visit thehoneypot.co.
About Compass Diversified (“CODI”)
Since its IPO in 2006, CODI has consistently
executed on its strategy of owning and managing a diverse set of
highly defensible, middle-market businesses across the industrial,
branded consumer, and healthcare sectors. CODI leverages its
permanent capital base, long-term disciplined approach, and
actionable expertise to maintain controlling ownership interests in
each of its subsidiaries, maximizing its ability to impact
long-term cash flow generation and value creation. CODI provides
both debt and equity capital for its subsidiaries, contributing to
their financial and operating flexibility. CODI utilizes the cash
flows generated by its subsidiaries to invest in the long-term
growth of the Company and has consistently generated strong returns
through its culture of transparency, alignment, and accountability.
For more information, please visit compassdiversified.com.
Forward Looking Statements
This press release may contain certain
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, including statements
with regard to the future performance of CODI, The Honey Pot Co.
and their affiliates. Words such as “believes,” “expects,”
“forward,” ”will,” and “future” or similar expressions, are
intended to identify forward-looking statements. These
forward-looking statements are subject to the inherent
uncertainties in predicting future results and conditions, some of
which are not currently known to CODI. Certain factors could cause
actual results to differ materially from those projected in these
forward-looking statements, and some of these factors are
enumerated in the risk factor discussion in the Form 10-K filed by
CODI with the SEC for the year ended December 31, 2023 and in other
filings with the SEC, including quarterly reports on Form 10-Q and
current reports on Form 8-K. Forward-looking statements speak only
as of the date they are made. Except as required by law, CODI
undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
Investor
Relationsirinquiry@compassdiversified.com
Gateway GroupCody
Slach949.574.3860CODI@gateway-grp.com
Compass Diversified Media
RelationsMediainquiry@compassdiversified.com
The IGB GroupLeon
Berman212.477.8438lberman@igbir.com
The Honey Pot Co. Media
Relationsthehoneypot@smallgirlspr.com
Compass Diversified (NYSE:CODI)
Historical Stock Chart
From Jan 2025 to Feb 2025
Compass Diversified (NYSE:CODI)
Historical Stock Chart
From Feb 2024 to Feb 2025